DEBRA OMLOR: Open Payments
NPI 1114166352 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 31 payments from 11 companies in 2025. Trend: 2023 $779 · 2024 $621 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $173 |
| PFIZER INC. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| UCB, Inc. | 2 | $52 |
| Organon LLC | 3 | $52 |
| Almirall LLC | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Incyte Corporation | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $23 |
| Journey Medical Corporation | 1 | $15 |
Products named: SKYRIZI, CIBINQO, RINVOQ, DUPIXENT, Bimzelx, OPZELURA, TREMFYA, VTAMA.
Industry payments across PA — which companies pay providers there.
